CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 65 filers reported holding CATALYST BIOSCIENCES INC in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $150,000 | +47.1% | 21,978 | +6.1% | 0.01% | +40.0% |
| Q3 2019 | $102,000 | -39.3% | 20,718 | -9.2% | 0.01% | -50.0% |
| Q2 2019 | $168,000 | +5.0% | 22,828 | +16.0% | 0.01% | 0.0% |
| Q1 2019 | $160,000 | +63.3% | 19,678 | +57.9% | 0.01% | +66.7% |
| Q4 2018 | $98,000 | -52.0% | 12,459 | -34.3% | 0.01% | -33.3% |
| Q3 2018 | $204,000 | – | 18,962 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |